Methylphenidate Conjugate (HRP)

Our Methylphenidate - HRP product is an Enzyme Conjugate based on a HRP (Horseradish Peroxidase) carrier, attached to proprietary Methylphenidate derivatives.

• Western blotting.
• Enzyme-linked immunosorbent assay (ELISA).
• Dot blotting.

Methylphenidate (MPH; Ritalin, Concerta, Metadate or Methylin) is a psychostimulant drug approved for treatment of attention-deficit hyperactivity disorder, postural orthostatic tachycardia syndrome, and narcolepsy. It may also be prescribed for off-label use in treatment-resistant cases of lethargy, depression, neural insult, obesity, and rarely other psychiatric disorders such as obsessive-compulsive disorder.